BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28774484)

  • 1. Cardiovascular disease risk associated with serum apolipoprotein B is modified by serum vitamin A.
    Olsen T; Vinknes KJ; Svingen GFT; Pedersen ER; Tell GS; Blomhoff R; Drevon CA; Ueland PM; Midttun Ø; Refsum H; Nygård OK
    Atherosclerosis; 2017 Oct; 265():325-330. PubMed ID: 28774484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk association of plasma total homocysteine with acute myocardial infarction is modified by serum vitamin A.
    Olsen T; Vinknes KJ; Svingen GF; Pedersen ER; Dhar I; Tell GS; Blomhoff R; Ueland PM; Midttun Ø; Refsum H; Nygård OK
    Eur J Prev Cardiol; 2018 Oct; 25(15):1612-1620. PubMed ID: 30014716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Glycine and Risk of Acute Myocardial Infarction in Patients With Suspected Stable Angina Pectoris.
    Ding Y; Svingen GF; Pedersen ER; Gregory JF; Ueland PM; Tell GS; Nygård OK
    J Am Heart Assoc; 2015 Dec; 5(1):. PubMed ID: 26722126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
    Liting P; Guoping L; Zhenyue C
    Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid parameters and vitamin A modify cardiovascular risk prediction by plasma neopterin.
    Dhar I; Siddique S; R Pedersen E; F T Svingen G; Lysne V; Olsen T; Nilsen DW; Nordrehaug JE; Midttun Ø; M Ueland P; S Tell G; K Nygård O
    Heart; 2020 Jul; 106(14):1073-1079. PubMed ID: 32398245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoproteins A1, B, and other prognostic biochemical cardiovascular risk factors in patients with beta-thalassemia major.
    Ghorban K; Shanaki M; Mobarra N; Azad M; Asadi J; Pakzad R; Ehteram H
    Hematology; 2016 Mar; 21(2):113-20. PubMed ID: 25913481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up.
    Bodde MC; Hermans MPJ; Jukema JW; Schalij MJ; Lijfering WM; Rosendaal FR; Romijn FPHTM; Ruhaak LR; van der Laarse A; Cobbaert CM
    Clin Res Cardiol; 2019 May; 108(5):520-538. PubMed ID: 30298424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
    Pan L; Lu G; Chen Z
    Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma methionine and risk of acute myocardial infarction: Effect modification by established risk factors.
    Dhar I; Lysne V; Seifert R; Svingen GFT; Ueland PM; Nygård OK
    Atherosclerosis; 2018 May; 272():175-181. PubMed ID: 29621698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris.
    Strand E; Pedersen ER; Svingen GF; Olsen T; Bjørndal B; Karlsson T; Dierkes J; Njølstad PR; Mellgren G; Tell GS; Berge RK; Svardal A; Nygård O
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neopterin as an Effect Modifier of the Cardiovascular Risk Predicted by Total Homocysteine: A Prospective 2-Cohort Study.
    Bjørnestad EØ; Borsholm RA; Svingen GFT; Pedersen ER; Seifert R; Midttun Ø; Ueland PM; Tell GS; Bønaa KH; Nygård O
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).
    Holme I; Aastveit AH; Jungner I; Walldius G
    J Intern Med; 2008 Jul; 264(1):30-8. PubMed ID: 18298486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
    van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
    Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computationally estimated apolipoproteins B and A1 in predicting cardiovascular risk.
    Raitakari OT; Mäkinen VP; McQueen MJ; Niemi J; Juonala M; Jauhiainen M; Salomaa V; Hannuksela ML; Savolainen MJ; Kesäniemi YA; Kovanen PT; Sundvall J; Solakivi T; Loo BM; Marniemi J; Hernesniemi J; Lehtimäki T; Kähönen M; Peltonen M; Leiviskä J; Jula A; Anand SS; Miller R; Yusuf S; Viikari JS; Ala-Korpela M
    Atherosclerosis; 2013 Jan; 226(1):245-51. PubMed ID: 23159013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial.
    Byun YS; Lee JH; Arsenault BJ; Yang X; Bao W; DeMicco D; Laskey R; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2015 Apr; 65(13):1286-1295. PubMed ID: 25835440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein B/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients.
    Zhan X; Chen Y; Yan C; Liu S; Deng L; Yang Y; Qiu P; Pan D; Zeng B; Chen Q
    Lipids Health Dis; 2018 May; 17(1):117. PubMed ID: 29776362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study.
    Lamprea-Montealegre JA; Sharrett AR; Matsushita K; Selvin E; Szklo M; Astor BC
    Atherosclerosis; 2014 May; 234(1):42-6. PubMed ID: 24607852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of serum apolipoprotein A1, B levels and their ratio with blood pressure in Chinese adults with coronary artery disease.
    Dong H; Yang X; Zhang Y; Hu P; Liu Y; Liang S
    Blood Press Monit; 2021 Dec; 26(6):401-406. PubMed ID: 34074807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apoB/apoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis.
    Öhman M; Öhman ML; Wållberg-Jonsson S
    Scand J Rheumatol; 2014; 43(4):259-64. PubMed ID: 24689997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B-to-A1 ratio as a predictor of acute ischemic nonembolic stroke in elderly subjects.
    Kostapanos MS; Christogiannis LG; Bika E; Bairaktari ET; Goudevenos JA; Elisaf MS; Milionis HJ
    J Stroke Cerebrovasc Dis; 2010; 19(6):497-502. PubMed ID: 20538481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.